Cite

HARVARD Citation

    Xu, S. et al. (2021). Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy. Advanced science. 8 (5), p. n/a. [Online]. 
  
Back to record